Drug class
Topical benzimidazole antifungal; early azole antimycotic
Mechanism of action
An early benzimidazole azole antifungal. The azole class inhibits fungal lanosterol 14-alpha-demethylase (CYP51), impairing ergosterol biosynthesis and compromising fungal cell-membrane integrity. The exact enzyme target was not established in the original chlormidazole development studies.
General use cases
- Historically marketed as 5% topical cream or tincture for dermatomycoses and Candida infections; products appear to have been withdrawn or are no longer widely available. This is a historical pharmacology entry, not a current routine treatment.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
